New drug trial targets genetic flaw in many advanced cancers
NCT ID NCT04639219
Summary
This study is testing whether the drug trastuzumab deruxtecan (T-DXd) can help control advanced solid tumors that have spread and contain specific HER2 gene mutations, regardless of where the cancer started in the body. It is for adults whose cancer has worsened after prior treatments or who have no other good treatment options. The main goal is to see how many patients' tumors shrink significantly and for how long.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS WITH HER2 MUTATION,EG:COLORECTAL,UROTHELIAL,GASTRIC, HEPATOBILIARY,ENDOMETRIAL,MELANOMA,OVARIAN,CERVICAL,SALIVARY GLAND,PANCREATIC,BREAST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Santa Rosa, California, 95403, United States
-
Research Site
Muncie, Indiana, 47303, United States
-
Research Site
Boston, Massachusetts, 02115, United States
-
Research Site
Boston, Massachusetts, 02215, United States
-
Research Site
Middletown, New Jersey, 07748, United States
-
Research Site
Commack, New York, 11725, United States
-
Research Site
Harrison, New York, 10604, United States
-
Research Site
New York, New York, 10021, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Fairfax, Virginia, 22031, United States
-
Research Site
Anderlecht, 1070, Belgium
-
Research Site
Toronto, CA, M5G 2M9, Canada
-
Research Site
Copenhagen, 2100, Denmark
-
Research Site
Bordeaux, 33076, France
-
Research Site
Lyon, 69008, France
-
Research Site
Villejuif, 94805, France
-
Research Site
Milan, 20141, Italy
-
Research Site
Milan, 20162, Italy
-
Research Site
Naples, 80131, Italy
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Kashiwa, 277-8577, Japan
-
Research Site
Suita-shi, 565-0871, Japan
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Madrid, 28041, Spain
-
Research Site
Madrid, 28050, Spain
-
Research Site
Pamplona, 31008, Spain
-
Research Site
Seville, 41013, Spain
Conditions
Explore the condition pages connected to this study.